Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
EClinicalMedicine (2021) - Comments
doi: 10.1016/j.eclinm.2021.100926  issn: 2589-5370  pubmed: 34109306 

Shaukat Ali, Syed Muneeb Uddin, Elisha Shalim, Muneeba Ahsan Sayeed, Fatima Anjum, Farah Saleem, Sheikh Muhammad Muhaymin, Ayesha Ali, Mir Rashid Ali, Iqra Ahmed, Tehreem Mushtaq, Sadaf Khan, Faisal Shahab, Shobha Luxmi, Suneel Kumar, Habiba Arain, Mujtaba Khan, Abdul Samad Khan, Hamid Mehmood, Abdur Rasheed